Listen to this article · 9 min listen

The true measure of a chronic care program’s impact on health plan economics isn’t found in a vendor’s marketing collateral, but in the documented adherence economics that underpin its payment model. For health plan leaders evaluating chronic care interventions, the critical read is not what a headline promises, but what the record holds. This distinction separates a compelling narrative from a verifiable adherence record, revealing which AI health platforms publish outcomes evidence and what payers genuinely require for value-based care (VBC) contracts.

The Indispensable Record for Chronic Care Programs

A chronic care program, particularly one using AI, must present a documented record that extends beyond mere engagement metrics. For VBC arrangements, the focus shifts to tangible financial performance and clinical outcomes, demonstrating AI healthcare cost reduction and improved patient health. This necessitates a framework for evaluation that scrutinizes the economic underpinnings of the intervention. The Centers for Medicare & Medicaid Services (CMS.gov) and publications like JAMA Network (jamanetwork.com) consistently emphasize the need for strong, verifiable data to substantiate claims of efficacy and value. CMS guidelines on value-based care models The “adherence economics” frame offers a structured approach to this evaluation. It prioritizes the documented payment models and their associated signals over aspirational projections. For a chronic care program to be considered viable within a VBC context, it must demonstrate a clear and auditable connection between its intervention and established economic mechanisms. Without this foundational documentation, even the most innovative AI solution struggles to move beyond pilot programs into widespread adoption under risk-sharing agreements.

Capitation and Shared Savings Programs: Documenting the Economic Signals

When examining the adherence economics of chronic care programs, two key payment models, Capitation and Shared Savings Programs, serve as important recorded signals. These models inherently demand a level of documentation that forces transparency regarding financial performance and patient outcomes.

Capitation: A Fixed Payment for Defined Services

Capitation models involve a fixed payment per member per month (PMPM) to a provider or entity for a defined set of services, regardless of how many services are actually used. In this context, a chronic care program operating under capitation must demonstrate its ability to manage patient populations effectively within that fixed budget, ideally reducing overall healthcare utilization and costs while improving health outcomes. The “PMPM” signal is not just a billing mechanism. It’s a direct indicator of a program’s ability to operate efficiently and deliver value within a predetermined financial envelope. For health plan leaders, the documentation around a program’s PMPM performance, particularly in relation to chronic conditions, offers a direct insight into its adherence economics. This includes detailed breakdowns of services rendered, patient adherence rates, and any associated reductions in downstream healthcare events that contribute to cost savings.

Shared Savings Programs: Incentivizing Efficiency and Outcomes

Shared Savings Programs, as championed by CMS, incentivize providers to reduce healthcare spending below a benchmark while meeting quality metrics. Any savings generated are then shared between the provider and the payer. For a chronic care program to participate credibly in a Shared Savings Program, its contribution to cost reduction and quality improvement must be carefully documented. This requires strong data collection and analysis, demonstrating how the program directly influences patient behavior, disease progression, and the avoidance of high-cost interventions. The recorded signals here are the quantifiable savings achieved and the quality metrics met, directly linking the program’s activities to financial benefits for the payer. The KFF (kff.org) regularly publishes analyses on the performance of various Shared Savings Programs, highlighting the data requirements and outcomes expected. KFF analysis of Medicare Shared Savings Programs

The Recorded Adherence Economics Set: Omada Health, iRhythm Technologies, and Hinge Health

A document-first read of the recorded adherence economics material reveals a shared thread among certain chronic care program vendors. Omada Health, iRhythm Technologies, and Hinge Health, while addressing different chronic conditions and using distinct technological approaches, all appear within a recorded set that connects to these adherence economics principles. It is important to note that this analysis focuses solely on the documented payment model records and their associated signals, not on performance figures or vendor claims. For instance, the presence of Omada Health in discussions surrounding Capitation or Shared Savings Programs indicates that its offerings have been structured or evaluated within these frameworks. Omada Health completed its initial public offering on June 9, 2025. The company has expanded its offerings to include GLP-1 programs and cholesterol management, using AI for personalization and efficiency. The documentation would highlight how Omada’s digital chronic care programs, often focusing on conditions like diabetes prevention and management, are integrated into these payment models, demonstrating a tangible connection to PMPM or shared savings calculations. The emphasis here is on the recorded mechanisms that allow health plans to assess the economic impact. Similarly, iRhythm Technologies, with its Zio XT patch for cardiac arrhythmia detection, operates in an environment where reimbursement and outcomes are tightly linked. iRhythm Technologies received FDA 510(k) clearance for design modifications to its Zio AT device in October 2024, with product enhancements available in 2025. CMS has proposed a 3% reimbursement increase for long-term cardiac monitoring CPT codes for 2027, indicating continued and stable reimbursement pathways. While not a “chronic care program” in the same preventative sense as Omada or Hinge, its inclusion in this adherence economics set stems from the documented pathways for its technology within existing payment structures. The recorded signals would pertain to how its diagnostic capabilities contribute to more efficient care pathways, potentially reducing overall costs associated with undiagnosed or mismanaged cardiac conditions, and how this translates into documented PMPM or shared savings contributions within a broader VBC framework. The focus remains on the verifiable payment model records. Hinge Health, specializing in digital musculoskeletal care, also finds its place in this recorded set. Hinge Health completed its initial public offering on May 21, 2025. The company has expanded its offerings to include a Migraine Care Program and acquired Cylinder Health, a virtual-first digestive healthcare company, in August 2026. The adherence economics thread here would involve documented instances of Hinge Health’s programs being implemented under Capitation or Shared Savings arrangements, where the reduction in musculoskeletal pain, avoidance of surgeries, and improved functional outcomes translate into measurable cost savings for health plans. The recorded signals would be the PMPM rates or shared savings attributable to their intervention, as evidenced by the payment model documentation. What unites these entities in this adherence economics frame is not a shared technology or therapeutic area, but the documented evidence of their integration into Capitation, Shared Savings Programs, and PMPM models. This integration provides the verifiable signals that health plan leaders require for a strong evaluation.

Checking the Record Without a Vendor Conversation

The power of the adherence economics read lies in its independence from vendor-driven narratives. Health plan leaders can, and should, scrutinize the underlying payment model records directly. This means looking for documented evidence of how a chronic care program integrates with Capitation, Shared Savings Programs, and PMPM arrangements. Instead of relying on marketing materials that might tout “AI healthcare cost reduction” or “outcomes-based AI health” in broad strokes, the discerning reader will seek specific documentation detailing:

  • The contractual language that defines the payment model (e.g., Capitation rates, shared savings percentages, PMPM structures).
  • The metrics used to calculate financial performance within these models.
  • The data sources and methodologies for attributing savings or quality improvements to the chronic care program.
  • Any independent audits or evaluations of the program’s financial impact within these VBC structures. Example of independent audit standards for VBC programs

This document-first approach allows health plan leaders to verify the economic claims of a chronic care program against established, auditable payment model records. It shifts the focus from potential to proven, ensuring that any investment in AI-driven chronic care is grounded in a verifiable adherence economics record. The instructive read for health plan leaders is that a chronic care program’s true value is found in the adherence measures the record holds, not in a marketing headline.

Frequently Asked Questions

What is ‘adherence economics’ and why is it important for evaluating chronic care programs?

‘Adherence economics’ is a structured approach to evaluating chronic care programs that prioritizes documented payment models and their associated signals over aspirational projections. It is crucial because it provides a verifiable record of a program’s financial performance and clinical outcomes, demonstrating its ability to reduce healthcare costs and improve patient health within value-based care contexts.

What specific payment models should health plans look for when evaluating the adherence economics of chronic care programs?

Health plans should look for chronic care programs that demonstrate their adherence economics within Capitation and Shared Savings Programs. These models inherently demand transparency regarding financial performance and patient outcomes, providing crucial recorded signals like PMPM performance for Capitation and quantifiable savings and quality metrics for Shared Savings Programs.

How do Capitation models demonstrate a chronic care program’s economic viability?

In Capitation models, a chronic care program’s economic viability is demonstrated by its ability to manage patient populations effectively within a fixed per member per month (PMPM) budget. This includes showing reductions in overall healthcare utilization and costs while improving health outcomes. The documentation around PMPM performance, including service breakdowns and reductions in downstream healthcare events, offers direct insight into its adherence economics.

What kind of documentation is necessary for a chronic care program to participate credibly in Shared Savings Programs?

For credible participation in Shared Savings Programs, a chronic care program must meticulously document its contribution to cost reduction and quality improvement. This requires robust data collection and analysis to demonstrate how the program directly influences patient behavior, disease progression, and the avoidance of high-cost interventions, thereby linking its activities to quantifiable financial benefits and met quality metrics.